Brevan Howard Capital Management’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.25M	Buy	+23,426	New	+$1.25M	0.01%	873
2025 Q1	–	Sell	-9,879	Closed	-$275K	–	1090
2024 Q4	$275K	Sell	9,879 -4,373	-31%	-$122K	﹤0.01%	777
2024 Q3	$409K	Buy	14,252 +4,061	+40%	+$117K	﹤0.01%	685
2024 Q2	$239K	Buy	+10,191	New	+$239K	﹤0.01%	793